SIMCERE PHARMA Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China Read more
Kriya Announces $270 Million Series C Financing to Advance Fully Integrated Gene Therapy Engine Read more
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission Read more
Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement Read more
Statera Biopharma and Lay Sciences Inc. Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY Products Read more
Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases Read more
Editas Medicine Receives FDA Orphan Drug Designation for EDIT-301 for the Treatment of Beta Thalassemia Read more